Commonwealth Equity Services’s OncoSec Medical Incorporated ONCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-263
Closed -$32K 2851
2019
Q1
$32K Buy
263
+43
+20% +$5.87K ﹤0.01% 2682
2018
Q4
$30K Sell
220
-218
-50% -$54.8K ﹤0.01% 2603
2018
Q3
$134K Buy
438
+25
+6% +$7.68K ﹤0.01% 2600
2018
Q2
$125K Buy
413
+65
+19% +$22.8K ﹤0.01% 2566
2018
Q1
$143K Buy
348
+172
+98% +$70.6K ﹤0.01% 2486
2017
Q4
$63K Buy
+176
New +$61.7K ﹤0.01% 2552

Other funds holding ONCS

Commonwealth Equity Services's ONCS Position: Q2 2019 in Review

Commonwealth Equity Services sold out of OncoSec Medical Incorporated (ONCS) in Q2 2019, closing a stake of 263 shares — an estimated $32K sold.

Commonwealth Equity Services first reported a position in ONCS in Q4 2017 and held it in 6 quarters. The position peaked at $143K in Q1 2018. 20 funds tracked by Wall St. Rank hold ONCS as of Q2 2019.

  • Commonwealth Equity Services reported no remaining OncoSec Medical Incorporated position as of Q2 2019 after selling out during the quarter.
  • Commonwealth Equity Services sold 263 OncoSec Medical Incorporated shares in Q2 2019, an estimated $32K.
  • Commonwealth Equity Services first reported a position in OncoSec Medical Incorporated in Q4 2017 and held it in 6 quarters.
  • Commonwealth Equity Services's OncoSec Medical Incorporated position peaked at $143K in Q1 2018.
  • 20 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q2 2019.

Based on Commonwealth Equity Services's 13F filing for Q2 2019, filed 19 Jul 2019.